Global Kaposi Sarcoma Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Kaposi's sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised.
Scope of the Report:
This report studies the Kaposi Sarcoma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Kaposi Sarcoma market by product type and applications/end industries.
Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
The global Kaposi Sarcoma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Kaposi Sarcoma.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Kaposi Sarcoma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Kaposi Sarcoma market by product type and applications/end industries.
Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
The global Kaposi Sarcoma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Kaposi Sarcoma.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Aphios
- Bristol Myers Squibb
- Cytori Therapeutics
- CytRx
- Eli Lilly and Company
- GlaxoSmithKline
- Roche
- Johnson and Johnson
- Merck
- Pfizer
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Classic
- Endemic
- Immunosuppresion Therapy-Related
- Epidemic
- Hospital
- Cancer Research Institution
- Clinics
1 KAPOSI SARCOMA MARKET OVERVIEW
1.1 Product Overview and Scope of Kaposi Sarcoma
1.2 Classification of Kaposi Sarcoma by Types
1.2.1 Global Kaposi Sarcoma Revenue Comparison by Types (2017-2023)
1.2.2 Global Kaposi Sarcoma Revenue Market Share by Types in 2017
1.2.3 Classic
1.2.4 Endemic
1.2.5 Immunosuppresion Therapy-Related
1.2.6 Epidemic
1.3 Global Kaposi Sarcoma Market by Application
1.3.1 Global Kaposi Sarcoma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Cancer Research Institution
1.3.4 Clinics
1.4 Global Kaposi Sarcoma Market by Regions
1.4.1 Global Kaposi Sarcoma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kaposi Sarcoma Status and Prospect (2013-2023)
1.5 Global Market Size of Kaposi Sarcoma (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Aphios
2.1.1 Business Overview
2.1.2 Kaposi Sarcoma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aphios Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol Myers Squibb
2.2.1 Business Overview
2.2.2 Kaposi Sarcoma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol Myers Squibb Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cytori Therapeutics
2.3.1 Business Overview
2.3.2 Kaposi Sarcoma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cytori Therapeutics Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.4 CytRx
2.4.1 Business Overview
2.4.2 Kaposi Sarcoma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CytRx Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly and Company
2.5.1 Business Overview
2.5.2 Kaposi Sarcoma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly and Company Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Kaposi Sarcoma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Kaposi Sarcoma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson and Johnson
2.8.1 Business Overview
2.8.2 Kaposi Sarcoma Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson and Johnson Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Kaposi Sarcoma Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Kaposi Sarcoma Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL KAPOSI SARCOMA MARKET COMPETITION, BY PLAYERS
3.1 Global Kaposi Sarcoma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Kaposi Sarcoma Players Market Share
3.2.2 Top 10 Kaposi Sarcoma Players Market Share
3.3 Market Competition Trend
4 GLOBAL KAPOSI SARCOMA MARKET SIZE BY REGIONS
4.1 Global Kaposi Sarcoma Revenue and Market Share by Regions
4.2 North America Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.3 Europe Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.5 South America Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA KAPOSI SARCOMA REVENUE BY COUNTRIES
5.1 North America Kaposi Sarcoma Revenue by Countries (2013-2018)
5.2 USA Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5.3 Canada Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5.4 Mexico Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6 EUROPE KAPOSI SARCOMA REVENUE BY COUNTRIES
6.1 Europe Kaposi Sarcoma Revenue by Countries (2013-2018)
6.2 Germany Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.3 UK Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.4 France Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.5 Russia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.6 Italy Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC KAPOSI SARCOMA REVENUE BY COUNTRIES
7.1 Asia-Pacific Kaposi Sarcoma Revenue by Countries (2013-2018)
7.2 China Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.3 Japan Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.4 Korea Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.5 India Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA KAPOSI SARCOMA REVENUE BY COUNTRIES
8.1 South America Kaposi Sarcoma Revenue by Countries (2013-2018)
8.2 Brazil Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8.3 Argentina Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8.4 Colombia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE KAPOSI SARCOMA BY COUNTRIES
9.1 Middle East and Africa Kaposi Sarcoma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.3 UAE Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.4 Egypt Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.6 South Africa Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
10 GLOBAL KAPOSI SARCOMA MARKET SEGMENT BY TYPE
10.1 Global Kaposi Sarcoma Revenue and Market Share by Type (2013-2018)
10.2 Global Kaposi Sarcoma Market Forecast by Type (2018-2023)
10.3 Classic Revenue Growth Rate (2013-2023)
10.4 Endemic Revenue Growth Rate (2013-2023)
10.5 Immunosuppresion Therapy-Related Revenue Growth Rate (2013-2023)
10.6 Epidemic Revenue Growth Rate (2013-2023)
11 GLOBAL KAPOSI SARCOMA MARKET SEGMENT BY APPLICATION
11.1 Global Kaposi Sarcoma Revenue Market Share by Application (2013-2018)
11.2 Kaposi Sarcoma Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Cancer Research Institution Revenue Growth (2013-2018)
11.5 Clinics Revenue Growth (2013-2018)
12 GLOBAL KAPOSI SARCOMA MARKET SIZE FORECAST (2018-2023)
12.1 Global Kaposi Sarcoma Market Size Forecast (2018-2023)
12.2 Global Kaposi Sarcoma Market Forecast by Regions (2018-2023)
12.3 North America Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.4 Europe Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.6 South America Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Kaposi Sarcoma Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Kaposi Sarcoma
1.2 Classification of Kaposi Sarcoma by Types
1.2.1 Global Kaposi Sarcoma Revenue Comparison by Types (2017-2023)
1.2.2 Global Kaposi Sarcoma Revenue Market Share by Types in 2017
1.2.3 Classic
1.2.4 Endemic
1.2.5 Immunosuppresion Therapy-Related
1.2.6 Epidemic
1.3 Global Kaposi Sarcoma Market by Application
1.3.1 Global Kaposi Sarcoma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Cancer Research Institution
1.3.4 Clinics
1.4 Global Kaposi Sarcoma Market by Regions
1.4.1 Global Kaposi Sarcoma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Kaposi Sarcoma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kaposi Sarcoma Status and Prospect (2013-2023)
1.5 Global Market Size of Kaposi Sarcoma (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Aphios
2.1.1 Business Overview
2.1.2 Kaposi Sarcoma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aphios Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol Myers Squibb
2.2.1 Business Overview
2.2.2 Kaposi Sarcoma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol Myers Squibb Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cytori Therapeutics
2.3.1 Business Overview
2.3.2 Kaposi Sarcoma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cytori Therapeutics Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.4 CytRx
2.4.1 Business Overview
2.4.2 Kaposi Sarcoma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CytRx Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly and Company
2.5.1 Business Overview
2.5.2 Kaposi Sarcoma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly and Company Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Kaposi Sarcoma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Kaposi Sarcoma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson and Johnson
2.8.1 Business Overview
2.8.2 Kaposi Sarcoma Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson and Johnson Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Kaposi Sarcoma Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Kaposi Sarcoma Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Kaposi Sarcoma Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL KAPOSI SARCOMA MARKET COMPETITION, BY PLAYERS
3.1 Global Kaposi Sarcoma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Kaposi Sarcoma Players Market Share
3.2.2 Top 10 Kaposi Sarcoma Players Market Share
3.3 Market Competition Trend
4 GLOBAL KAPOSI SARCOMA MARKET SIZE BY REGIONS
4.1 Global Kaposi Sarcoma Revenue and Market Share by Regions
4.2 North America Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.3 Europe Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.5 South America Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA KAPOSI SARCOMA REVENUE BY COUNTRIES
5.1 North America Kaposi Sarcoma Revenue by Countries (2013-2018)
5.2 USA Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5.3 Canada Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
5.4 Mexico Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6 EUROPE KAPOSI SARCOMA REVENUE BY COUNTRIES
6.1 Europe Kaposi Sarcoma Revenue by Countries (2013-2018)
6.2 Germany Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.3 UK Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.4 France Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.5 Russia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
6.6 Italy Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC KAPOSI SARCOMA REVENUE BY COUNTRIES
7.1 Asia-Pacific Kaposi Sarcoma Revenue by Countries (2013-2018)
7.2 China Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.3 Japan Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.4 Korea Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.5 India Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA KAPOSI SARCOMA REVENUE BY COUNTRIES
8.1 South America Kaposi Sarcoma Revenue by Countries (2013-2018)
8.2 Brazil Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8.3 Argentina Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
8.4 Colombia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE KAPOSI SARCOMA BY COUNTRIES
9.1 Middle East and Africa Kaposi Sarcoma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.3 UAE Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.4 Egypt Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
9.6 South Africa Kaposi Sarcoma Revenue and Growth Rate (2013-2018)
10 GLOBAL KAPOSI SARCOMA MARKET SEGMENT BY TYPE
10.1 Global Kaposi Sarcoma Revenue and Market Share by Type (2013-2018)
10.2 Global Kaposi Sarcoma Market Forecast by Type (2018-2023)
10.3 Classic Revenue Growth Rate (2013-2023)
10.4 Endemic Revenue Growth Rate (2013-2023)
10.5 Immunosuppresion Therapy-Related Revenue Growth Rate (2013-2023)
10.6 Epidemic Revenue Growth Rate (2013-2023)
11 GLOBAL KAPOSI SARCOMA MARKET SEGMENT BY APPLICATION
11.1 Global Kaposi Sarcoma Revenue Market Share by Application (2013-2018)
11.2 Kaposi Sarcoma Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Cancer Research Institution Revenue Growth (2013-2018)
11.5 Clinics Revenue Growth (2013-2018)
12 GLOBAL KAPOSI SARCOMA MARKET SIZE FORECAST (2018-2023)
12.1 Global Kaposi Sarcoma Market Size Forecast (2018-2023)
12.2 Global Kaposi Sarcoma Market Forecast by Regions (2018-2023)
12.3 North America Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.4 Europe Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.6 South America Kaposi Sarcoma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Kaposi Sarcoma Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Kaposi Sarcoma Picture
Table Product Specifications of Kaposi Sarcoma
Table Global Kaposi Sarcoma and Revenue (Million USD) Market Split by Product Type
Figure Global Kaposi Sarcoma Revenu
Figure Kaposi Sarcoma Picture
Table Product Specifications of Kaposi Sarcoma
Table Global Kaposi Sarcoma and Revenue (Million USD) Market Split by Product Type
Figure Global Kaposi Sarcoma Revenu
